Pathway to Cures

Venture Capital Investor Investment Firm

Pathway to Cures (P2C) is a venture philanthropy fund driven by a singular mission to accelerate the development of cures across all inheritable blood and bleeding disorders. P2C collaborates with various organizations to invest in innovative therapies and technologies while reinvesting proceeds from investments back into the Fund to amplify their impact.

Firm Investment Focus

Investment Stages

Seed

Focus Areas

Life Sciences & Healthcare
Recent Activity

Deal activity and portfolio updates would appear here

Connect your data source to see recent transactions